Abstract:Objective To explore the clinical effect of artificial liver combined with Entecavir in the treatment of chronic subacute liver failure.Methods A total of 70 patients with chronic subacute early liver failure admitted to Ganzhou Fifth People′s Hospital from October 2017 to February 2019 were selected as the research subjects,they were divided into the control group (35 cases) and the experimental group (35 cases) according to the odd-even numbers.The control group was treated with conventional medical treatment and Entecavir,while the experimental group was treated with artificial liver combined with Entecavir on the basis of conventional medical treatment.The liver function index,treatment effect,anxiety and depression status and the ability of daily living were compared between the two groups.Results The prealbumin (PA) and cholinesterase (CHE) of the experimental group were higher than those of the control group,and the total serum bilirubin (TBil) was lower than that of the control group,the differences were statistically significant (P<0.05).The total effective rate of the experimental group was higher than that of the control group,the difference was statistically significant (P<0.05).The self-rating anxiety scale (SAS) and self-rating depression scale(SDS) scores in the experimental group were lower than those in the control group,and the activities of daily living scale (Barthel) score in the experimental group was higher than that in the control group,the differences were statistically significant (P<0.05).Conclusion For chronic and subacute liver failure (early stage) disease,the clinical use of artificial liver combined with entecavir is effective and worthy of clinical promotion.
罗颖敏;曾艺军;包龙远;刘长虹. 人工肝联合恩替卡韦治疗慢加亚急性肝衰竭的临床效果[J]. 中国当代医药, 2021, 28(7): 43-45.
LUO Ying-mi;ZENG Yi-jun BAO ;Long-yuan LIU ;Chang-hong. Clinical effect of artificial liver combined with Entecavir in the treatment of chronic subacute liver failure. 中国当代医药, 2021, 28(7): 43-45.